Reborna Biosciences ^None

Reborna Biosciences focuses on researching and developing therapeutic options for rare genetic diseases. They use technology that allows low-molecular compounds to target RNA, which can lead to the development of new disease-modifying drugs. One of the rare genetic diseases they work on is spinal muscular atrophy. The company aims to contribute to society by providing medication that targets RNA for patients and families affected by genetic rare diseases.